Cutler Group LP 9 Meters Biopharma, Inc. Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$0.21 - $0.32 $105 - $160	500 Added 12.82%	4,400 $0
Q1 2022 Apr 14, 2022	BUY	$0.52 - $1.0 $572 - $1,100	1,100 Added 39.29%	3,900 $2,000
Q4 2021 Jan 18, 2022	SELL	$0.85 - $1.33 $1,020 - $1,596	-1,200 Reduced 30.0%	2,800 $2,000
Q2 2021 Jul 19, 2021	SELL	$1.04 - $1.5 $5,928 - $8,550	-5,700 Reduced 58.76%	4,000 $4,000
Q1 2021 Apr 26, 2021	BUY	$0.84 - $2.16 $5,796 - $14,904	6,900 Added 246.43%	9,700 $11,000
Q2 2020 Jul 22, 2020	BUY	$0.43 - $0.74 $1,204 - $2,072	2,800 New	2,800 $1,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.